Michael Ouk

Also affiliated with University of Toronto, Canada Research Chairs, Ontario Brain Institute, Sunnybrook Research Institute

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “The use of angiotensin-converting enzyme inhibitors vs. angiotensin receptor blockers and cognitive decline in Alzheimer’s disease: the importance of blood-brain barrier penetration and APOE ε4 carrier status”.

The use of angiotensin-converting enzyme inhibitors vs. angiotensin receptor blockers and cognitive decline in Alzheimer’s disease: the importance of blood-brain barrier penetration and APOE ε4 carrier status

Alzheimer s Research & Therapy(2021)10.1186/s13195-021-00778-8

N/A

0DataRank · unranked

69 citations

Che‐Yuan Wu, Jennifer S. Rabin, Aaron Jackson, Jodi D. Edwards, Joel Ramirez +7 more

Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer’s dementia

Alzheimer s Research & Therapy(2021)10.1186/s13195-021-00892-7

N/A

0DataRank · unranked

30 citations

Michael Ouk, Che‐Yuan Wu, Jennifer S. Rabin, Krista L. Lanctôt, Nathan Herrmann +4 more

Biofluid markers of blood-brain barrier disruption and neurodegeneration in Lewy body spectrum diseases: A systematic review and meta-analysis

Parkinsonism & Related Disorders(2022)10.1016/j.parkreldis.2022.06.004

N/A

0DataRank · unranked

42 citations

Che‐Yuan Wu, Di Yu, Esther Kim, Melissa H. Wong, Renata Elez +13 more